Suchergebnisse - "Scleroderma"

PubPharm (8.001)

1

Systemic sclerosis with morphea-like plaques histopathologically mimicking cutaneous B-cell lymphoma

enthalten in: JAAD case reports | 2024

von Aragon Sierra, A. | Hwang, A. | Kechter, J. | +3

2

Post-marketing Surveillance on Long Term Use of Ofev Capsules in Systemic Scleroderma Associated Interstitial Lung Disease (SSc-ILD) in Japan : Post-marketing Surveillance on Long Term Use of Ofev Capsules in Systemic Scleroderma Associated Interstitial Lung Disease (SSc-ILD) in Japan

enthalten in: ClinicalTrials.gov | 2024

3

An Clinical Study of YTS109 Cell Injection in Subjects With Recurrent/Refractory Autoimmune Disease : An Exploratory Clinical Study of the Safety and Efficacy of YTS109 Cell Injection in Subjects With Recurrent/Refractory Autoimmune Disease

enthalten in: ClinicalTrials.gov | 2024

4

Cadherin-11 targeted cell-specific liposomes enabled skin fibrosis treatment by inducing apoptosis

enthalten in: Journal of controlled release : official journal of the Controlled Release Society | 2024

von Bhatt, H. | Diwan, R. | Estevao, I. | +5

5

Aberrant Long-Chain Fatty Acid Metabolism Associated with Evolving Systemic Sclerosis-Associated Pulmonary Arterial Hypertension

enthalten in: American journal of physiology. Lung cellular and molecular physiology | 2024

von Coursen, J. | Tuhy, T. | Naranjo, M. | +9

6

Superb microvascular imaging for evaluating the activity of juvenile localised scleroderma : a preliminary study

enthalten in: European radiology | 2024

von Chen, X. | Zhou, L. | Xia, Y. | +7

7

Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer : A Phase Ib Study of Nivolumab in Patients With Autoimmune Disorders and Advanced Malignancies (AIM-NIVO)

enthalten in: ClinicalTrials.gov | 2024

8

An Open-label, Phase 2 Study to Assess the Efficacy and Safety of Nemolizumab in Subjects With Systemic Sclerosis : An Open-label, Phase 2 Study to Assess the Efficacy and Safety of Nemolizumab in Subjects With Systemic Sclerosis

enthalten in: ClinicalTrials.gov | 2024

9

Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD) : Randomized, Double-blind, Placebo-controlled Proof-of-Concept (PoC) Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)

enthalten in: ClinicalTrials.gov | 2024

10

Safety of prolonged use of metoclopramide and domperidone as treatment for chronic gastrointestinal dysmotility disorders in patients with systemic sclerosis

enthalten in: Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society | 2024

von Alkhowaiter, S. | Al Rasheed, M. | Alammar, N. | +5

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[801]